Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baucus Flags Comparative Effectiveness As Priority For Senate Medicare Bill

Executive Summary

Comparative effectiveness research continues to have traction in Congress. The issue has been flagged as a priority item for inclusion in the Senate Finance Committee forthcoming package of Medicare and other health care provisions, according to a top health aide to committee Chairman Max Baucus, D-Mont
Advertisement

Related Content

More Research, Little Action On Comparative Effectiveness In Medicare Bill
More Research, Little Action On Comparative Effectiveness In Medicare Bill
Part D’s Six Protected Drug Classes May Ride Baucus Medicare Vehicle
ARB Marketers May Be Tense After AHRQ Comparative Effectiveness Report
ARB Marketers May Be Tense After AHRQ Comparative Effectiveness Report
GlaxoSmithKline Selects European Head Witty To Succeed Garnier As CEO
Benzodiazepine Coverage Among Medicare Provisions In Child Health Bill
Benzodiazepine Coverage Among Medicare Provisions In Child Health Bill
Part D Enrollees Like Stability, Low Premiums, Analysis Of 2007 Plan Choices Finds
Medicare Bill Could Spur Interest In Drug Comparative Effectiveness Studies
Advertisement
UsernamePublicRestriction

Register

PS048833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel